Currently, the molecular characteristic of HDFCO is elusive for lack of common gene abnormalities seen in typical cervical thyroid cancer and struma-derived papillary carcinoma, such as BRAF, RAS, p53, and PPARg-PAX8 gene fusion [8, 10, 13, 14]. This evidence concerns the gene BRAF and papillary carcinoma.